Weight change and its impact on prognosis after adjuvant TAC (docetaxel–doxorubicin–cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer

Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal

(2014) J Chilcott et al.   HEALTH TECHNOLOGY ASSESSMENT

Weight Change and Survival after Breast Cancer in the After Breast Cancer Pooling Project

(2012) B. J. Caan et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study

(2011) Shannon M. Conroy et al.   BREAST CANCER RESEARCH AND TREATMENT

Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project

(2011) Marilyn L. Kwan et al.   BREAST CANCER RESEARCH AND TREATMENT

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

(2010) N. Hatam et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse

(2010) Emilie Thivat et al.   BMC CANCER

Obesity and weight change in relation to breast cancer survival

(2010) Xiaoli Chen et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

(2010) Melinda Protani et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of Obesity on Prognosis After Early-Stage Breast Cancer

(2010) Marianne Ewertz et al.   JOURNAL OF CLINICAL ONCOLOGY

Body Mass Index Before and After Breast Cancer Diagnosis: Associations with All-Cause, Breast Cancer, and Cardiovascular Disease Mortality

(2009) H. B. Nichols et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: Data from the randomised SBG 2000-1 study

(2009) Mikkel Rosendahl et al.   EUROPEAN JOURNAL OF CANCER

Cost–effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)

(2008) Sang Gyu Lee et al.   BREAST CANCER RESEARCH AND TREATMENT

Weight changes after adjuvant treatment in Korean women with early breast cancer

(2008) Hye-Suk Han et al.   BREAST CANCER RESEARCH AND TREATMENT

REMOVED: Docetaxel-related side effects and their management

(2008) Jackie Baker et al.   European Journal of Oncology Nursing